What federal law might supersede the governing state law in the Dermani Medspa franchise agreement?

According to the 2025 Dermani Medspa Franchise Disclosure Document, a violation of federal law may occur if Dermani Medspa Franchising LLC does not deliver the disclosure document on time or if it contains a false or misleading statement or a material omission. In such cases, the document indicates that this should be reported to the Federal Trade Commission (FTC) in Washington, D.C. This implies that the FTC, as a federal entity, has the authority to investigate and potentially take action against Dermani Medspa if there are violations of federal law related to franchise disclosure.

This is significant for prospective Dermani Medspa franchisees because it highlights their right to a timely and accurate disclosure document. If the disclosure contains false statements, omissions, or is not provided within the mandated time frame, franchisees have recourse through the FTC. This federal oversight serves as a layer of protection, ensuring that Dermani Medspa adheres to federal standards of franchise disclosure.

It is important for potential Dermani Medspa franchisees to understand that while state laws govern many aspects of the franchise agreement, federal laws, particularly those enforced by the FTC, can supersede state laws in cases of non-compliance with disclosure requirements. This federal oversight aims to protect franchisees from deceptive or unfair practices during the franchise sales process. Therefore, franchisees should carefully review the disclosure document and report any discrepancies or delays to both the FTC and the appropriate state agency.